Clinical Trial Update: Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of low molecular weight heparin for superficial thrombophlebitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Superficial Thrombophlebitis

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Superficial Thrombophlebitis | Phase 4 | Status: COMPLETED